Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)

China · Delayed Price · Currency is CNY

29.55

-0.62 (-2.06%)

At close: Mar 9, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Diagnostic Kits/Equipment		242.31M	258.21M	424.30M	290.95M	284.93M
Diagnostic Kits/Equipment Growth		-6.16%	-39.14%	45.83%	2.11%	11.53%
Total		242.31M	258.21M	424.30M	290.95M	284.93M
Total Growth		-6.16%	-39.14%	45.83%	2.11%	11.53%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China		242.31M	258.21M	424.30M	290.95M	284.93M
China Growth		-6.16%	-39.14%	45.83%	2.11%	11.53%
Total		242.31M	258.21M	424.30M	290.95M	284.93M
Total Growth		-6.16%	-39.14%	45.83%	2.11%	11.53%

Source: S&P Global Market Intelligence.